Here’s the first part of my column on the recent Congressional investigation into the genomcs industry: The genomics industry, which provides reports about disease risk, ancestry, and drug reactions based on one’s DNA, came under fire last week as a Congressional Committee held hearings and the Government Accountability Office (GAO) released an unscientific “study” of [...]

continue reading.....